Position in PAHC
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$4,952,752
-$4,819,140 QoQ
Shares Held
157,731
-10.7% QoQ
Ownership
0.388%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#29
of 206 holders
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 90%
Shared 0%
None 10%
Common Shares in PAHC Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026JPMORGAN CHASE & CO holds $2,415,050,910 across 61 Drug Manufacturers - Specialty & Generic names. PAHC ranks #25 (0.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | NBIX |
Neurocrine Biosciences Inc
|
6,398,674 | $1,078,432,506 | |
| 2 | TEVA |
Teva Pharmaceutical Industries Ltd
|
6,981,234 | $236,524,202 | |
| 3 | ZTS |
Zoetis Inc.
|
2,624,825 | $188,619,917 | |
| 4 | HIMS |
Hims & Hers Health, Inc.
|
4,766,781 | $165,264,292 | |
| 5 | UTHR |
UNITED THERAPEUTICS Corp
|
275,358 | $149,197,220 | |
| 6 | VTRS |
Viatris Inc
|
7,322,267 | $116,277,595 | |
| 7 | HLN |
Haleon plc
|
10,824,395 | $100,991,599 | |
| 8 | LNTH |
Lantheus Holdings, Inc.
|
699,229 | $77,572,458 |
All Filings in PAHC
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $4,952,752 | 157,731 | Shares | Other | 2026-08-12 | |
| 2026-03-31 | $9,771,892 | 176,675 | Shares | Defined | 2026-05-13 | |
| 2025-12-31 | $10,143,873 | 271,517 | Shares | Defined | 2026-02-11 | |
| 2025-09-30 | $9,634,130 | 238,115 | Shares | Defined | 2025-11-07 | |
| 2025-06-30 | $332,145 | 13,005 | Shares | Defined | 2025-08-12 | |
| 2025-03-31 | $270,031 | 12,642 | Shares | Defined | 2025-05-12 | |
| 2024-12-31 | $243,285 | 11,585 | Shares | Defined | 2025-02-12 | |
| 2024-09-30 | $255,352 | 11,339 | Shares | Defined | 2024-12-26 | |
| 2024-06-30 | $188,544 | 11,243 | Shares | Defined | 2024-12-26 | |
| 2024-03-31 | $214,249 | 16,570 | Shares | Defined | 2024-12-26 | |
| 2023-12-31 | $1,172,681 | 101,268 | Shares | Defined | 2024-12-26 | |
| 2023-09-30 | $1,093,941 | 85,665 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $227,817 | 16,629 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $639,762 | 41,760 | Shares | Defined | 2023-05-18 | |
| 2022-12-31 | $515,049 | 38,408 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $528,874 | 39,795 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $765,925 | 40,038 | Shares | Defined | 2022-08-11 | |
| 2022-03-31 | $827,285 | 41,468 | Shares | Defined | 2022-05-11 | |
| 2021-12-31 | $1,673,357 | 81,947 | Shares | Defined | 2022-02-11 | |
| 2021-09-30 | $1,820,945 | 84,538 | Shares | Defined | 2021-11-12 | |
| 2021-06-30 | $2,113,379 | 73,178 | Shares | Defined | 2021-08-12 | |
| 2020-12-31 | $1,104,026 | 56,850 | Shares | Defined | 2021-02-19 | |
| 2020-09-30 | $1,139,700 | 65,500 | Shares | Defined | 2020-11-12 | |
| 2020-06-30 | $1,654,535 | 62,982 | Shares | Defined | 2020-08-11 | |
| 2020-03-31 | $2,785,905 | 115,263 | Shares | Defined | 2020-05-12 | |
| No filing history on record for this holder in this stock. | ||||||